New biomarkers for detecting cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 21-Jun-2026 22:16 ET (22-Jun-2026 02:16 GMT/UTC)
New research from Fox Chase Cancer Center, presented at the American Association for Cancer Research annual meeting, suggests melanoma behaves differently with age. The data showed cancer spread was the lowest in young mice, peaked in middle‑aged mice, and declined in very old mice.
A tiny antibody component could fundamentally transform the treatment of cystic fibrosis: For the first time, researchers have succeeded in developing a so-called nanobody that penetrates directly into human cells and can repair the chloride channel most commonly affected in cystic fibrosis. The innovative therapeutic approach was developed in collaboration between teams from Charité – Universitätsmedizin Berlin and the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP). The results have now been published in the journal Nature Chemical Biology*.
MIT chemists have found that changing the composition of the cell membrane can alter the function of EGFR, a cell receptor that promotes proliferation and is often overactive in cancer cells.
The gut microbiota drives changes to the immune system caused by chronic sleep loss. These changes promote cancer progression, disrupt circadian rhythm and weaken the effectiveness of chemotherapy.
According to a study from MIT, NDMA, a carcinogen that has been found in some drugs and drinking water contaminated by chemical plants, may have a much more severe impact on children than adults.
New work demonstrates that editing just a handful of blood stem cells can permanently program the immune system to manufacture therapeutic proteins, which can be boosted through vaccination. This proof of concept, demonstrated in mice, shows that this strategy could one day enable durable treatments in humans for HIV, influenza, cancer, and metabolic disease.